Statement on joint media release from the REMAP-CAP, ACTIV-4 and ATTACC trials regarding anticoagulation
24 December, 2020
The Taskforce acknowledges the publication of a joint media release from the REMAP-CAP, ACTIV-4 and ATTACC trial teams on December 22nd, 2020. The investigators have reported that among critically ill COVID-19 patients requiring intensive care unit (ICU) support, therapeutic anticoagulation drugs did not improve outcome measured using a composite of in-hospital mortality and duration of organ failure support in hospital...